Antonius Ter Laak

USPTO Granted Patents = 11 (Patent Applications = 13)

EPO Patents = 8 (Patent Applications = 20)

Average Co-Inventor Count = 8.9

ph-index = 2

Forward Citations = 32(Granted Patents)

Company Filing History:

6 out of 378

Bayer Pharma Aktiengesellschaft

patents

3 out of 192

Bayer Schering Pharma Ag

patents

2 out of 12,157

Bayer Aktiengesellschaft

patents

4. 1 out of 443

The Broad Institute, Inc.

patents

5. 1 out of 721

Bayer Intellectual Property Gmbh

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12357603 - Acyl sulfonamides for treating cancer (2025-07-15),

2. 11161825 - 4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides (2021-11-02),

3. 10654818 - Furane derivatives as inhibitors of ATAD2 (2020-05-19),

4. 10167293 - [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones (2019-01-01),

5. 10023539 - Aryl-cyanoguanidine compounds (2018-07-17),

6. 9708311 - Benzimidazole derivatives as EP4 antagonists (2017-07-18),

7. 9655887 - Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception (2017-05-23),

8. 9062041 - [object Object] (2015-06-23),

9. 7977325 - 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents (2011-07-12),

10. 7842809 - Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of same (2010-11-30),

11. 7795264 - Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same (2010-09-14),

Title: The Innovative Contributions of Antonius Ter Laak

Introduction

Antonius Ter Laak is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 11 patents to his name, Ter Laak's work has the potential to impact the medical community profoundly.

Latest Patents

One of his latest patents involves acyl sulfonamides for treating cancer. This invention provides acyl sulfonamide compounds of general formula (I): 4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides. The patent covers these compounds, methods of preparing them, and their use in pharmaceutical compositions for the treatment or prophylaxis of diseases, particularly cancer. This innovation highlights Ter Laak's commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Antonius Ter Laak has worked with prominent companies in the pharmaceutical industry, including Bayer Pharma Aktiengesellschaft and Bayer Schering Pharma AG. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.

Collaborations

Ter Laak has collaborated with notable colleagues, including Roman Hillig and Nico Bräuer. These partnerships have likely facilitated the exchange of ideas and expertise, further enhancing the quality and impact of his inventions.

Conclusion

Antonius Ter Laak's contributions to the field of pharmaceuticals, particularly in cancer treatment, demonstrate his innovative spirit and dedication to improving healthcare. His patents and collaborations reflect a commitment to advancing medical science, making him a significant figure in the industry.

This text is generated by artificial intelligence and may not be accurate.